You are here
- Home
- Therapy Areas
- Gastrointestinal
A multicentre, double-blind, randomised, parallel-group, Phase III study to assess efficacy and safety of D9421-C 9 mg versus Mesalazine 3 g in patients with active Crohn’s Disease (CD) in Japan
- Disease
- Crohn's disease
- Drug Name
- Entocort capsules
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IIIa
- Start Date
- Jan 18, 1971
- Study Name
- D9423C00001
- Study Id
- D9423C00001
- ClinicalTrials.gov ID
- NCT01514240
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
